The Center for Vascular Biology Research was formed in 2004 as part of a strategic plan to establish interdisciplinary centers of excellence at Beth Israel Deaconess Medical Center.
Dr. Harold Dvorak served as the founding Director of the CVBR. He is internationally recognized for his discovery of the protein now known as Vascular Endothelial Growth Factor (VEGF). This discovery led to the blossoming of numerous areas of vascular biology research, which are still yielding promising advances in the treatment of such illnesses as cancer and heart disease. The most significant of these to date is the FDA's approval of the anti-angiogenesis drug, Avastin to treat patients with advanced cancer.
In 2008, Dr. Dvorak was succeeded by
Dr. William Aird as Director of the CVBR, and
Laura Benjamin was appointed the Associate Director.
In October 2008, the CVBR was consolidated under one roof at Research North, 330 Brookline Avenue, where today over 100 faculty members, postdoctoral fellows and students work side by side.